  See all
|
Article Summary
|
|
|
Joanne N.G. Oude Elberink MD, et al. - Venom immunotherapy (VIT) is a treatment with established efficacy for the prevention of repeated anaphylactic reactions in patients with Hymenoptera allergy, which also allows patients to discontinue carrying an EpiPen...Conclusion: In contrast to VIT, the EpiPen is perceived as burdensome by most patients with venom allergy. For most patients, an EpiPen is an unsuitable definitive treatment. As VIT enables patients with venom allergy to get rid of the EpiPen, patients should be offered VIT
|
 |
|
Read a Different Specialty |
|
|
|
|
|
Profession Index
|
|
|
|
|
|
|
|
